Guides, explainers, and analysis on EU and global policy institutions, legislative processes, and the evolving practice of policy monitoring. Designed for teams who need to move from reactive tracking to proactive advocacy.
Browse our full library of explainers, policy primers, and monitoring playbooks. Use the filters above to narrow by topic.
The EU's Carbon Border Adjustment Mechanism (CBAM) introduces a carbon tax on imports, creating significant financial risk for industrial portfolios. This guide…
Manual spreadsheets can't keep up with modern regulatory risk. Discover how an AI-powered risk intelligence platform enables automated compliance monitoring for PE…
Navigate Japan's complex pharmaceutical market with our expert guide. Understand the core challenges of the MHLW-led drug pricing system, key repricing rules…
This practical guide explains the UFLPA Entity List and its impact on US importers. Follow our step-by-step framework for UFLPA compliance to…
US pharma faces growing risks from Chinese API dependency. This guide explains why traditional methods fail and outlines a proactive framework for…
Understand the EU's Spitzenkandidaten process, the controversial system for electing the European Commission President. This guide explains how it works, its history,…
Discover how German state elections reshape federal energy and climate policy through the powerful Bundesrat. Learn why tracking these regional votes is…
The rise of GLP-1s has fractured the patient advocacy landscape, creating new risks and opportunities for pharma. This case study analyzes the…
Internal echo chambers create strategic blind spots that can derail even the most well-planned advocacy strategy. Learn why external validation is critical…
Introduction The Post-Brexit Regulatory Divide for Chemicals For any company in the chemical sector, REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals)…
The EU-Mercosur trade deal is no longer just about tariffs. New EU regulations like EUDR and CSDDD create major compliance hurdles related…
Discover why traditional stakeholder matrix mapping is a dangerously outdated tool for navigating the complex world of EU pharmaceutical policy. Learn how…
Articles explain the landscape. Policy-Insider.AI monitors it for you — continuously, configured to your organization's issues, stakeholders, and geographies.
Start a free pilot →